Carolina Maciel Camargo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carolina Maciel Camargo has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Kenneth S. Kosik
University of California, Santa Barbara
3 shared publications - Mookwang Kwon
University of California Santa Barbara
2 shared publications - Andrew Paul Longhini
University of California Santa Barbara
1 shared publication - Arina A. Nikitina
Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
1 shared publication - Barbara Mejía-Cupajita
Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
1 shared publication Bárbara Mejía-Cupajita
1 shared publication
Latest Publications
- Open Access
BAG2 Condensates Couple Proteostasis to CD8+T Cell Surveillance
Protein aggregation, impaired degradation, and immune activation are central hallmarks of neurodegenerative diseases, yet how these processes are coordinated remains unclear. Here, we identify Immune-Protein Degradation Bodies (I-PDBs), a previously unrecognized class of BAG2-driven, phase-separated organelles that integrate protein quality control with adaptive immunity. IFN-gamma; induce I-PDB formation at the endoplasmic reticulum (ER), where they concentrate immunoproteasome components, MHC-I peptide-loading machinery, and ER-associated chaperones. I-PDBs redirect proteostatic cargo from centrosomal aggregation pathways to spatially restricted degradation sites optimized for antigenic peptide generation, coupling selective substrate clearance to CD8+ T cell engagement. Using a cellular model of aggregation-prone tau, we show that I-PDBs capture pathological tau fibrils at ER-microtubule interfaces and process them into potentially antigenic peptides, thus reducing the load of aggregation-prone tau peptides. We term this mechanism the Proteostasis-Associated Immune Relay (PAIR), establishing I-PDBs as critical hubs linking proteostasis to immune surveillance with broad implications for disease.
Open AccessBAG2 Condensates Couple Proteostasis to CD8+T Cell Surveillance
Protein aggregation, impaired degradation, and immune activation are central hallmarks of neurodegenerative diseases, yet how these processes are coordinated remains unclear. Here, we identify Immune-Protein Degradation Bodies (I-PDBs), a previously unrecognized class of BAG2-driven, phase-separated organelles that integrate protein quality control with adaptive immunity. IFN-gamma; induce I-PDB formation at the endoplasmic reticulum (ER), where they concentrate immunoproteasome components, MHC-I peptide-loading machinery, and ER-associated chaperones. I-PDBs redirect proteostatic cargo from centrosomal aggregation pathways to spatially restricted degradation sites optimized for antigenic peptide generation, coupling selective substrate clearance to CD8+ T cell engagement. Using a cellular model of aggregation-prone tau, we show that I-PDBs capture pathological tau fibrils at ER-microtubule interfaces and process them into potentially antigenic peptides, thus reducing the load of aggregation-prone tau peptides. We term this mechanism the Proteostasis-Associated Immune Relay (PAIR), establishing I-PDBs as critical hubs linking proteostasis to immune surveillance with broad implications for disease.
- Open Access
Neuronal Population Effects of Ketamine on Human Brain Organoids
Ketamine’s rapid neuropsychiatric actions emerge from interactions that span receptors, cells, and circuits, but their net effects on human neuronal population dynamics remain incompletely defined. Here we combine human dorsal forebrain organoids with high-density microelectrode arrays (MEAs) to quantify ketamine’s effects from spikes to networks. In 6-month-old organoids, acute ketamine (20□μg/mL) abolished population bursting while neuronal firing continued mostly unchanged. Spike sorting revealed that mean firing rates declined but not silenced after ketamine Reductions were concentrated within a subset of burst-driver units previously defined as “backbone”. Functional connectivity, estimated with the spike time tiling coefficient (STTC), decreased globally after ketamine. Backbone units displayed elevated connectivity at baseline but were functionally disconnected by ketamine. Graph construction from STTC uncovered widespread network reconfiguration, characterized by redistribution of edges from backbone to non-backbone units leading to loss of hubs and less-interconnected communities. Re-exposure after chronic ketamine treatment no longer silenced population bursting, indicating tolerance. Together, these results show that ketamine acutely silences human organoid networks by disconnecting backbone units, while chronic exposure induces tolerance to re-silencing while reducing the number of backbone units and leaving the network less active and less connected. The organoid-MEA platform provides a scalable, human-relevant system for dissecting circuit-level drug effects.
Open AccessNeuronal Population Effects of Ketamine on Human Brain Organoids
Ketamine’s rapid neuropsychiatric actions emerge from interactions that span receptors, cells, and circuits, but their net effects on human neuronal population dynamics remain incompletely defined. Here we combine human dorsal forebrain organoids with high-density microelectrode arrays (MEAs) to quantify ketamine’s effects from spikes to networks. In 6-month-old organoids, acute ketamine (20□μg/mL) abolished population bursting while neuronal firing continued mostly unchanged. Spike sorting revealed that mean firing rates declined but not silenced after ketamine Reductions were concentrated within a subset of burst-driver units previously defined as “backbone”. Functional connectivity, estimated with the spike time tiling coefficient (STTC), decreased globally after ketamine. Backbone units displayed elevated connectivity at baseline but were functionally disconnected by ketamine. Graph construction from STTC uncovered widespread network reconfiguration, characterized by redistribution of edges from backbone to non-backbone units leading to loss of hubs and less-interconnected communities. Re-exposure after chronic ketamine treatment no longer silenced population bursting, indicating tolerance. Together, these results show that ketamine acutely silences human organoid networks by disconnecting backbone units, while chronic exposure induces tolerance to re-silencing while reducing the number of backbone units and leaving the network less active and less connected. The organoid-MEA platform provides a scalable, human-relevant system for dissecting circuit-level drug effects.
- Open Access
Progranulin loss induces mitochondrial dysfunction and ferroptosis in human cerebral organoids
Loss-of-function mutations in the granulin ( GRN ) gene cause frontotemporal dementia when the mutations are heterozygous and neuronal ceroid lipofuscinosis, a lysosomal storage disease, when homozygous. While it is well established that disease-causing GRN mutations decrease progranulin (PGRN) levels, leading to neurodegeneration, the cellular and molecular mechanisms underlying these conditions remain poorly understood. In this study, we utilized human induced pluripotent stem cell (iPSC) derived forebrain organoids to investigate the impact of PGRN homozygous deficiency on neuronal and glial cell populations. Through single-cell RNA sequencing, we identified robust downregulation of the mitochondrial oxidative phosphorylation pathway in PGRN KO organoids. In line with these results, PGRN KO organoids showed decreased mitochondrial respiration. Furthermore, our study demonstrated that PGRN loss induced increased levels of reactive oxygen species (ROS), lipid peroxidation and iron accumulation. Finally, we observed increased vulnerability to ferroptotic cell death in PGRN KO organoids. Our findings suggest that mitochondrial dysfunction and impaired responses to oxidative stress are early manifestations of PGRN loss, and offer insights into the molecular mechanisms driving neurodegeneration caused by PGRN deficiency. Abstract Figure: Graphical Abstract Proposed molecular mechanisms that lead to ferroptosis of PGRN KO cells. Created with BioRender.com .:
Open AccessProgranulin loss induces mitochondrial dysfunction and ferroptosis in human cerebral organoids
Loss-of-function mutations in the granulin ( GRN ) gene cause frontotemporal dementia when the mutations are heterozygous and neuronal ceroid lipofuscinosis, a lysosomal storage disease, when homozygous. While it is well established that disease-causing GRN mutations decrease progranulin (PGRN) levels, leading to neurodegeneration, the cellular and molecular mechanisms underlying these conditions remain poorly understood. In this study, we utilized human induced pluripotent stem cell (iPSC) derived forebrain organoids to investigate the impact of PGRN homozygous deficiency on neuronal and glial cell populations. Through single-cell RNA sequencing, we identified robust downregulation of the mitochondrial oxidative phosphorylation pathway in PGRN KO organoids. In line with these results, PGRN KO organoids showed decreased mitochondrial respiration. Furthermore, our study demonstrated that PGRN loss induced increased levels of reactive oxygen species (ROS), lipid peroxidation and iron accumulation. Finally, we observed increased vulnerability to ferroptotic cell death in PGRN KO organoids. Our findings suggest that mitochondrial dysfunction and impaired responses to oxidative stress are early manifestations of PGRN loss, and offer insights into the molecular mechanisms driving neurodegeneration caused by PGRN deficiency. Abstract Figure: Graphical Abstract Proposed molecular mechanisms that lead to ferroptosis of PGRN KO cells. Created with BioRender.com .:
- 1 December 2025
- Published by AIP Publishing in Review of Scientific Instruments
- Vol. 96 (12)
Controlled-environment platform for electrophysiology recordings on organoids with Neuropixels 2.0
We present a custom recording platform that enables electrophysiological recordings with Neuropixels 2.0 from human brain and heart organoids by maintaining a stable, physiological environment of 5% CO2, 37 °C, and 95% relative humidity. The platform combines a modular positioning system with real-time camera guidance for precise probe alignment. We validated the system by recording consistent bursting activity in brain organoids over a 110-min period and in heart organoids for up to 11 h.
- 1 December 2025
- Published by AIP Publishing in Review of Scientific Instruments
- Vol. 96 (12)
Controlled-environment platform for electrophysiology recordings on organoids with Neuropixels 2.0
We present a custom recording platform that enables electrophysiological recordings with Neuropixels 2.0 from human brain and heart organoids by maintaining a stable, physiological environment of 5% CO2, 37 °C, and 95% relative humidity. The platform combines a modular positioning system with real-time camera guidance for precise probe alignment. We validated the system by recording consistent bursting activity in brain organoids over a 110-min period and in heart organoids for up to 11 h.